TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharmor AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,473
|
1,991
|
2,033 |
Financial expenses |
213
|
292
|
425 |
Earnings before taxes |
1,078
|
617
|
796 |
EBITDA |
1,102
|
869
|
961 |
Total assets |
3,885
|
3,048
|
2,758 |
Current assets |
986
|
1,268
|
1,155 |
Current liabilities |
682
|
611
|
475 |
Equity capital |
2,915
|
2,199
|
2,061 |
- share capital |
34
|
33
|
36 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
75.0%
|
72.1%
|
74.7% |
Turnover per employee |
2,473
|
1,991
|
2,033 |
Profit as a percentage of turnover |
43.6%
|
31.0%
|
39.2% |
Return on assets (ROA) |
33.2%
|
29.8%
|
44.3% |
Current ratio |
144.6%
|
207.5%
|
243.2% |
Return on equity (ROE) |
37.0%
|
28.1%
|
38.6% |
Change turnover |
472
|
123
|
345 |
Change turnover % |
24%
|
7%
|
20% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.